| 09.30 - 10.00 |
Osler Room |
|
|
COFFEE |
| |
|
|
| 10.00 - 11.00 |
Wolfson Theatre |
|
|
Plenary Lecture: European Medal Lecture |
|
|
Chair: Franks S (London) |
| |
|
|
| S1 |
10.00 |
Gene-modified
animal models in the study of pituitary-gonadal function |
|
|
Huhtaniemi IT (Aberdeen) |
| |
|
|
| 11.00 - 13.00 |
Wolfson Theatre |
|
|
Symposium 1: Novel aspects of thyroid
diseases |
|
|
Chair: Franklyn J (Birmingham) and Lazarus
J (Cardiff) |
| |
|
|
| S5 |
11.00 |
Thyroid
hormone actions on bone and growth |
|
|
Williams GR (London) |
| |
|
|
| S6 |
11.30 |
Specific
roles of thyroid hormone receptor isoforms during development of the
mouse |
|
|
Samarut J (Lyon, France) |
| |
|
|
| S7 |
12.00 |
Molecular
diagnosis of thyroid cancer |
|
|
Ezzat S (Toronto, Canada) |
| |
|
|
| S8 |
12.30 |
Current
concepts in the pathogenesis of autoimmune thyroid disease |
|
|
Weetman AP (Sheffield) |
| |
|
|
| 11.00 - 13.00 |
Council Chamber |
|
|
Young Endocrinologists Session: Basic
Science Review Lecture |
|
|
Chair: Franks S (London) |
| |
|
|
| S4 |
11.00 |
Steroidogenic
Factor-1: A pivotal regulator of gonadotroph gene expression |
|
|
Fowkes R (London) |
| |
|
|
|
|
JOURNAL OF ENDOCRINOLOGY SYMPOSIUM:
YOUNG INNOVATIONS - SOCIETY FOR ENDOCRINOLOGY RESEARCH FELLOWS UPDATE |
|
|
Chair: Fowkes R (London) & Patel M (London) |
| |
|
|
| S21 |
11.30 |
Perinatal
glucocorticoid treatment, growth and the growth hormone axis |
|
|
Warne JP (London), Theogaraj E, John C, Houston
P, Smith S, Gillies G & Buckingham J |
| |
|
|
| S22 |
11.48 |
Truncated
cytokine receptors and GH antagonists: signalling and trafficking |
|
|
Maamra M (Sheffield) |
| |
|
|
| S23 |
12.06 |
Identification
and role of adenosine receptors in the pituitary gland |
|
|
Rees DA (Cardiff) |
| |
|
|
| S24 |
12.24 |
Thyroid
hormone action on bone |
|
|
Siddiqi A (London) |
| |
|
|
| S25 |
12.42 |
Methylation
of the POMC gene |
|
|
Newell-Price J (Sheffield), King P & Clark
AJL |
| |
|
|
| 11.00 - 13.00 |
Seligman Theatre |
|
|
Oral Communication 1: Growth regulation
and development |
|
|
Chair: Pell J (Cambridge) & Ross RJM
(Sheffield) |
| |
|
|
| OC1 |
11.00 |
Reduced
maternal nutrition in late gestation acts to decrease prolactin receptor
abundance in adipose tissue and later fat deposition |
|
|
Korur N, Pearce S, Dandrea J, Ingleton P,
Symonds ME & Stephenson T |
| |
|
|
| OC2 |
11.15 |
The
effect of chronic umbilical cord occlusion on mitochondrial protein abundance
in the late gestation ovine fetus |
|
|
Gnanalingham MG, Mostyn A, Giussani D, Stephenson
T, Symonds ME & Gardner D |
| |
|
|
| OC3 |
11.30 |
Influence
of genotype on the endocrine and metabolic control of uncoupling protein
(UCP)-2 during the first week of life in neonatal piglets |
|
|
Mostyn A, Litten J, Perkins KS, Symonds ME & Clarke
L |
| |
|
|
| OC4 |
11.45 |
Somatostatin
inhibits the release of ghrelin in normal subjects |
|
|
Tan TMM, Levy M, Skinner V, Beaumont N, Srai
K, Goadsby PJ, Bouloux PMG & Vanderpump MP |
| |
|
|
| OC5 |
12.00 |
27
years on - improved final height with growth hormone therapy after irradiation
for childhood brain tumours reflecting evolving endocrine practice |
|
|
Stoeter R, Gleeson HK, Ogilvy-Stuart AL & Shalet
SM |
| |
|
|
| OC6* |
12.15 |
Pulse
wave velocity and blood pressure are reduced by 6 months of growth hormone
therapy in adult growth hormone deficient patients |
|
|
McCallum RW, Petrie JR, Dominiczak AF & Connell
JMC |
| |
|
|
| OC7* |
12.30 |
Does
growth hormone reduce sensorineural deafness in adults with Turner syndrome? |
|
|
Ostberg JE, Beckman A, Cadge B & Conway
GS |
| |
|
|
| OC8* |
12.45 |
How
to optimise pegvisomant treatment of acromegaly safely |
|
|
Mukherjee A, Trainer PJ, Monson JE & Shalet
SM |
| |
|
|
| 13.00 - 13.30 |
Wolfson Theatre |
|
|
Society for Endocrinology AGM |
| |
|
|
| 13.00 - 13.30 |
LUNCH |
| |
|
|
| 13.30 - 14.30 |
Library |
| |
|
Attended Posters |
| |
|
|
| 14.00 - 16.30 |
Council Chamber |
| |
|
Nurses Session: The impact of thyroid
eye disease on body image |
|
|
Chair: Carson M (Edinburgh) & Holmes
C (Cambridge) |
| |
|
|
| S26 |
14.00 |
The
medical approach to thyroid eye disease |
|
|
Perros P (Newcastle) |
| |
|
|
| S27 |
14.30 |
Surgical
intervention |
|
|
Beaconsfield M (London) |
| |
|
|
| S28 |
15.00 |
Thyroid
eye disease psychosocial issues |
|
|
Frewin S (Newcastle) |
| |
|
|
| S29 |
15.30 |
Partnership
in practice: towards a better understanding of patient/doctor relationship |
|
|
Britton JS (TED) |
| |
|
|
|
|
CASE PRESENTATIONS |
| |
|
|
| S30 |
16.00 |
Patients
perspective on thyroid eye disease |
|
|
Kisalu JC (London) |
| |
|
|
| S31 |
16.07 |
From
hypothyroid to thyrotoxic with associated thyroid eye disease: a case
presentation |
|
|
Cox S (Torbay), Dyer RG, Cole M & Bliss
P |
| |
|
|
| 14.30 - 16.30 |
Wolfson Theatre |
|
|
Symposium 2: Ageing and cellular senescence |
|
|
Chair: Henderson I (Sheffield) & Withers
D (London) |
| |
|
|
| S9 |
14.30 |
Genetics
of ageing in invertebrates |
|
|
Partridge L (London) |
| |
|
|
| S10 |
15.00 |
Extending
lifespan |
|
|
Bartke A (Carbondale, USA), Dominici F & Turyn
D |
| |
|
|
| S11 |
15.30 |
Role
of oxidative stress in ageing |
|
|
Merry BJ (Liverpool) |
| |
|
|
| S12 |
16.00 |
Growth
hormone and ageing |
|
|
Sönksen PH (London) |
| |
|
|
| 14.30 - 16.30 |
Seligman Theatre |
|
|
Oral Communication 2: Endocrine tumours
and neoplasia |
|
|
Chair: Mason H (London) |
| |
|
|
| OC9 |
14.30 |
Role
of ceramide signalling during fenretinide and retinoic acid action on
ovarian cancer cells |
|
|
Schrey MP & Das TM |
| |
|
|
| OC10 |
14.45 |
The
role of insulin-like growth factor II and its intracellular mediators
in the control of chicken ovarian functions |
|
|
Sirotkin AV & Grossman R |
| |
|
|
| OC11 |
15.00 |
Ghrelin
exerts a proliferative effect on a rat pituitary somatotroph cell line |
|
|
Mozid AM, Fowkes RC, Morris DG, Sidhu K,
Khalaf S, Burrin JM, Grossman AB & Korbonits M |
| |
|
|
| OC12 |
15.15 |
The
effects of ghrelin on expression of growth hormone, IGF-1 and tumour
associated genes in cultured normal and malignant breast tissue explants |
|
|
Sen Gupta P, Laban CA, Ogunkolade BW, Bustin
SA, Carpenter R & Jenkins PJ |
| |
|
|
| OC13 |
15.30 |
Expression
of insulin-like growth factor binding protein-3 (IGFBP-3) is down regulated
in breast cancer compared to normal breast tissue |
|
|
McCarthy K, Laban CA, Bustin SA, Ogunkolade
BW, Carpenter R & Jenkins PJ |
| |
|
|
| OC14 |
15.45 |
Angiotensin
II induces C-FOS expression through PKC-zeta in MCF-7 breast cancer cell
line |
|
|
Muscella A, Greco S, Elia MG, Storelli C & Marsigliante
S |
| |
|
|
| OC15 |
16.00 |
Effect
of insulin-like growth factor binding protein-3 (IGFBP-3) on colon cancer
epithelial cells growth and apoptosis |
|
|
Saksena M, Miraki-Moud F, King P & Camacho-Hubner
C |
| |
|
|
| OC16 |
16.15 |
IGF-I
prevents deoxycholic acid-induced apoptosis in HT29 colorectal cells |
|
|
Khalaf S, Ogunkolade W, Davies D, Bustin
SA & Jenkins PJ |
| |
|
|
| 16.30 - 16.45 |
Osler Room |
|
|
TEA |
| |
|
|
| 16.45 - 17.45 |
Wolfson Theatre |
|
|
Plenary Lecture: Society for Endocrinology
Medal Lecture |
|
|
Chair: Franks S (London) |
| |
|
|
| S2 |
16.45 |
Transgenes
and physiology in the GH axis: tall tales from short tails |
|
|
Robinson ICAF (London) |